FTC Approves Thermo-Fisher Merger; Fisher to Divest Genevac Business | GenomeWeb
NEW YORK (GenomeWeb News) - Thermo Electron said yesterday that the US Federal Trade Commission has approved its $10.6 billion merger with Fisher Scientific International.
Thermo said the FTC has approved a consent order requiring the divestiture of Fisher's $17 million Genevac business and that it has granted the companies "early termination" of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.